Ligand efficacy and potency at recombinant human MT2 melatonin receptors: Evidence for agonist activity of some mt1-antagonists

British Journal of Pharmacology

Volumn 127, Issue 5, 1999, Pages 1288-1294

  Nonno, Romolo ^a   Pannacci, Marilou ^a   Lucini, Valeria ^a   Angeloni, Deborah ^a   Fraschini, Franco ^a   Stankov, Bojidar M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

35S GTP S binding; Melatonin; Melatonin analogues; Melatonin antagonists; MT2 receptor; Relative efficacy

Indexed keywords

2 IODOMELATONIN; 6 CHLOROMELATONIN; LUZINDOLE; MELATONIN; MELATONIN RECEPTOR; N ACETYLTRYPTAMINE;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; DRUG BINDING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; MELATONIN; MICE; PERTUSSIS TOXIN; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; RECOMBINANT PROTEINS; TRYPTAMINES; VIRULENCE FACTORS, BORDETELLA;

EID: 0032812567     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702658     Document Type: Article

References (34)

1. BARRETT, P., MACLEAN, A. & MORGAN, P.J. (1994). Evidence for multiple forms of melatonin receptor-G-protein complexes by solubilization and gel electrophoresis. J. Neuroendocrinol., 6, 509-515.
2. BIRNBAUMER. L., ABRAMOWITZ, J. & BROWN, A.M. (1990). Receptor-effector coupling by G proteins. Biochim. Biophys. Acta, 1031, 163-224.
3. BRADFORD, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal. Biochem., 72, 248-254.
4. CAGNACCI, A., ARANGINO, S., ANGIOLUCCI, M., MASCHIO, E. & MELIS, G.B. (1998). Influences of melatonin administration on the circulation of women. Am. J. Physiol., 274, R335-R338.
5. 50) of an enzymatic reaction. Biohem. Pharmacol., 22, 3099-3108.
6. COSIA, T., OGINO, Y., MUNSON, J.P., ONGUN ONARAN, H. & RODBARD, D. (1992). Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol., 41, 549-560.
7. DE LEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235, E97-E102.
8. DOLLINS, A.B., ZIIDANOVA, I.V., WURTMAN, R.J., LYNCH, H.J. & DENG, M.H. (1994). Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc. Natl. Acad. Sci. U.S.A., 91, 1824-1828.
9. DUBOCOVICH, M.L. (1988). Luzindole (N-0774): a novel melatonin receptor antagonist. J. Pharmacol. Exp. Ther., 246, 902-910.
10. 1 presynaptic heteroceptor. Naunyn-Schmiedeberg's Arch. Pharmacol., 355, 365-375.
11. DURANTI, E., STANKOV, B., SPADONI, G., DURANTI, A., LUCINI, V., CAPSONI, S., BIELLA, G. & FRASCHINI, F. (1992). 2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist. Life Sci., 51, 479-485.
12. FAUTEK, J.-D., LERCHL, A., BERGMANN, M., MOLLER, M., FRASCHINI, F., WITTKOVSKI, W. & STANKOV, B. (1994). The adult human cerebellum is a target of the neuroendocrine system involved in the circadian timing. Neurosci. Lett., 179, 60-64.
13. GARRATT, P.J., JONES, R. & TOCHER, DA. (1995). Mapping the melatonin receptor. 3. Design and synthesis of melatonin agonists and antagonists derivd from 2-phenyltryptamines. J. Med. Clem., 38, 1132-1139.
14. HILF, G., GIERSHIK, P. & JACOBS. K.H. (1989). Muscarinic acetyleholine receptor-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to guanine nucleotide-binding proteins in cardiac membranes. Eur. J. Biochem., 186, 725-731.
15. LEW, M.J. & ANGUS, J.A. (1995). Analysis of competitive agonist-antagonist interactions by nonlinear regression. Trends Pharmacol. Sci., 16, 328-337.
16. LEWY, A.J., SACK, R.L., AHMED, S., BAUER, V.K. & BLOOD, M.L. (1995). The influence of melatonin on the human circadian clock. In The Pineal Gland and Its Hormones: Fundamentals and Clinical Perspectives. ed. Fraschini, F., Reiter, R.J. & Stankov, B. pp. 173-182, Nato Asi Series. New York: Plenum Press.
17. LIU, C., WEAVER, D.R., JIN, X., SHEARMAN, L.P., PIESCHL, R.L., GRIBKOFF, V.K. & REPPERT, S.M. (1998). Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron, 19, 91-102.
18. 35S]thio)triphosphate binding. Mol. Pharmacol., 44, 115-123.
19. MAZZUCCHELLI, C., PANNACCI, M., NONNO, R., LUCINI, V., FRASCHINI, F. & STANKOV, B.M. (1996). The melatonin receptor in the human brain: cloning experiments and distribution studies. Mol. Brain Res., 39, 117-126.
20. MORGAN, P.J., BARRET, P., HOWELL, H.E. & HELLIWELL, R. (1994). Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem. Int., 24, 101-146.
21. 1 adenosine receptor/G protein coupling: Identification of a membrane protein that stabilizes the association of the receptor/G protein complex. Mol. Pharmacol., 48, 806-817.
22. NANOFF, C., WALDHOER, M., ROKA, F. & FREISSMUTH, M. (1997). G protein coupling of the rat A1-adenosine receptor Partial purification of a protein which stabilizes the receptor-G protein association. Neuropharmacology. 36, 1211-1219.
23. 1a receptor following stable transfection into NIH3T3 cells. Br. J. Pharmacol., 124, 485-492.
24. 125F]Iodomelatonin binding sites in the bovine hippocampus are not sensitive to guanine nucleotides. Neurosci. Lett., 194, 113-116.
25. 1b melatonin receptor. Proc. Natl. Acad. Sci. U.S.A., 92, 8734-8738.
26. REPPERT, S.M., WEAVER, D.R. & EBISAWA, T. (1994). Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron, 13, 1177-1185.
27. REPPERT, S.M., WEAVER, D.R. & GOODSON, C. (1996). Melatonin receptors step into the light. Trends Pharmacol. Sci., 17, 100-102.
28. SPADONI, G., STANKOV, B., DURANTI, A., BIELLA, G., LUCINI, V., SALVATORI, A. & FRASCHINI, F. (1993). 2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity. J. Med. Chem., 36, 4069-4074.
29. STANKOV, B., COZZI, B., LUCINI, V., FUMAGALLI, P., SCAGLIONE, F. & FRASCHINI, F. (1991). Characterization and mapping of melatonin receptors in the brain of three mammalian species: rabbit, horse and sheep. Neuroendocrinology, 53, 214-221.
30. SUGDEN, D. (1992). Effect of putative melatonin receptor antagonists on melatonin induced pigment aggregation in isolated Xenopus laevis melanophores. Eur. J. Pharmacol., 213, 405-408.
31. TAKAKI, K.S., MAHLE, C.D. & WATSON, A.J. (1997). Melatoninergic ligands: pharmaceutical development and clinical applications. Curr. Pharmacol. Design, 3, 429-438.
32. 1A receptors to adenylyl cyclase. Mol. Pharmacol., 41, 999-1007.
33. VENTER, D.P. (1997). Efficacy I: a new method for estimating the relative efficacy of full agonists via a newly defined efficacy related parameter. Eur. J. Pharmacol., 320, 223-231.
34. 2-dopamine receptor of the anterior pituitary gland. Mol. Pharmacol., 26, 214-227.